Cited by 550Gastrointestinal motility and disordersStatistical Methods in Clinical TrialsEthics in Clinical Research

The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.

Design of Treatment Trials for Functional Gastrointestinal Disorders

Irvine, E. Jan, Tack, Jan, Crowell, Michael D., Gwee, Kok Ann, Ke, Meiyun, Schmulson, Max J., Whitehead, William E., Spiegel, Brennan·2016·Gastroenterology

DOI 10.1053/j.gastro.2016.02.010

Open this paper in CoChat — free account

Abstract

This article summarizes recent progress and regulatory guidance on design of trials to assess the efficacy of new therapies for functional gastrointestinal disorders (FGIDs). The double-masked, placebo-controlled, parallel-group design remains the accepted standard for evaluating treatment efficacy. A control group is essential, and a detailed description of the randomization process and concealed allocation method must be included in the study report. The control will most often be placebo, but for therapeutic procedures and for behavioral treatment trials, respectively, a sham procedure and control intervention with similar expectation of benefit, but lacking the treatment principle, are recommended. Investigators should be aware of, and attempt to minimize, expectancy effects (placebo, nocebo, precebo). The primary analysis should be based on the proportion of patients in each treatment arm who satisfy a treatment responder definition or a prespecified clinically meaningful change in a patient-reported outcome measure. Data analysis should use the intention-to-treat principle. Reporting of results should follow the Consolidated Standards for Reporting Trials guidelines and include secondary outcome measures to support or explain the primary outcome and an analysis of harms data. Trials should be registered in a public location before initiation and results should be published regardless of outcome.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2016.02.010

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The McGill Pain Questionnaire: Major properties and scoring methods
Melzack, R. (1975) · Pain · doi:10.1016/0304-3959(75)90044-5 · Cited by 6,873
Multilevel analysis : an introduction to basic and advanced multilevel modeling
Snijders, T. A. B., & Bosker, R. (1999) · Cited by 6,830
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Measurement of health status
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339

Flagged first, then by citations

Show all 151 references

4 of the 151 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 550

Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome
Carbone, F., Vandenberghe, A., Holvoet, L., Vanuytsel, T., Oudenhove, L. V., Jones, M., & Tack, J. F. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13753 · Cited by 54
Self-citation
Prediction of Treatment Outcome of Patients with Functional Gastrointestinal Disorders by the Diagnostic Criteria for Psychosomatic Research
Porcelli, P., Carne, M. D., & Todarello, O. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000076454 · Cited by 54
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort—Results of an International Multicenter Randomized Controlled Trial
Gearry, R. B., Fukudo, S., Barbara, G., Kuhn‐Sherlock, B., Ansell, J., Blatchford, P. A., Eady, S. L., Wallace, A. J., Butts, C. A., Cremon, C., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002124 · Cited by 54
Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome
Ingrosso, M. R., Ianiro, G., Nee, J. W., Lembo, A. J., Moayyedi, P., Black, C. J., & Ford, A. C. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17179 · Cited by 56
Treatment of irritable bowel syndrome with osteopathy: Results of a randomized controlled pilot study
Hundscheid, H. W., Pepels, M. J. A. E., Engels, L. G. J. B., & Loffeld, R. J. L. F. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04741.x · Cited by 54
Response rate and predictors of response in a short‐term empirical trial of high‐dose rabeprazole in patients with globus
Sinn, D. H., Kim, J. H., Kim, S., Son, H. J., Kim, J. J., Rhee, P., & Rhee, P. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03659.x · Cited by 51
Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
Bensoussan, A., Kellow, J., Bourchier, S. J., Fahey, P., Shim, L., Malcolm, A., & Boyce, P. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.022 · Cited by 46
Comparison of breath testing with fructose and high fructose corn syrups in health and IBS
Skoog, S. M., Bharucha, A. E., & Zinsmeister, A. R. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01074.x · Cited by 51
Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
Fukudo, S., Nakamura, M., Hamatani, T., Kazumori, K., & Miwa, H. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.019 · Cited by 42
Placebo‐ and paracetamol‐controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain
Mueller‐Lissner, S., Tytgat, G. N. J., Paulo, L. G., Quigley, E. M. M., Bubeck, J., Peil, H., & Schaefer, E. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02818.x · Cited by 49
Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists
Rutten, J. M. T. M., Vlieger, A. M., Frankenhuis, C., George, E. K., Groeneweg, M., Norbruis, O. F., Ten, W. T. A., van Wering, H. M., Dijkgraaf, M. G. W., Merkus, M. P., et al. (2014) · BMC Pediatrics · doi:10.1186/1471-2431-14-140 · Cited by 49
“It has been designed according to methodological recommendations on the design of treatment trials for gastrointestinal disorders and has several strengths [29].”
Method
Naloxone treatment for irritable bowel syndrome — a randomized controlled trial with an oral formulation
Hawkes, N., Rhodes, J., Evans, B. K., Rhodes, P., Hawthorne, A. B., & Thomas, G. A. O. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01320.x · Cited by 49
Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome
den Houte, K. V., Colomier, E., Routhiaux, K., Mariën, Z., Schol, J., den Bergh, J. V., Vanderstappen, J., Pauwels, N., Joos, A., Arts, J., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.02.008 · Cited by 52
Self-citation
Fructose-sorbitol malabsorption
Fernández‐Bañares, F., Esteve, M., & Viver, J. M. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0056-9 · Cited by 48
Study design considerations for irritable bowel syndrome clinical trials.
Miller, L. E. (2014) · Europe PMC (PubMed Central) · Cited by 48
Glucomannan is not effective for the treatment of functional constipation in children: A double-blind, placebo-controlled, randomized trial
Chmielewska, A., Horvath, A., Dziechciarz, P., & Szajewska, H. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.01.012 · Cited by 48
Treatment Effects of Partially Hydrolyzed Guar Gum on Symptoms and Quality of Life of Patients with Irritable Bowel Syndrome. A Multicenter Randomized Open Trial
Parisi, G., Bottona, E., Carrara, M., Cardin, F., Faedo, A., Goldin, D., Marino, M., Pantalena, M., Tafner, G., Verdianelli, G., et al. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2713-7 · Cited by 48
The Irritable Bowel Syndrome Outcome Study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome
Lackner, J. M., Keefer, L., Jaccard, J. J., Firth, R. S., Brenner, D. M., Bratten, J. R., Dunlap, L. J., Ma, C., & Byroads, M. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.07.013 · Cited by 50
A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial
Pinheiro, I., Robinson, L. E., Verhelst, A., Marzorati, M., Winkens, B., den Abbeele, P. V., & Possemiers, S. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1948-0 · Cited by 51
Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial
Horvath, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i20.3062 · Cited by 47
Is Visceral Hypersensitivity Correlated With Symptom Severity in Children With Functional Gastrointestinal Disorders?
Castilloux, J., Noble, A. J., & Faure, C. C. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31814b91e7 · Cited by 46
Childhood predictors of recurrent abdominal pain in adolescence: A 13-year population-based prospective study
Helgeland, H., Sandvik, L., Mathiesen, K. S., & Kristensen, H. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.10.010 · Cited by 46
The Bowel Function Index: a new validated scale for assessing opioid-induced constipation
Ducrotte, P. R., & Caussé, C. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.657301 · Cited by 46
Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
Park, J.-W., Lee, B.-H., & Lee, H. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-247 · Cited by 45
The interpretation of Rome III criteria and method of assessment affect the irritable bowel syndrome classification of children
Czyzewski, D. I., Lane, M. M., Weidler, E. M., Williams, A. E., Swank, P. R., & Shulman, R. J. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04535.x · Cited by 45
Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome
Lackner, J. M., Jaccard, J. J., Firth, R. S., Krasner, S. S., Hamilton, F. A., Keefer, L., Ma, C., Radziwon, C. D., Sitrin, M. D., Brenner, D. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.033 · Cited by 47
Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents
Clayton, E. H., Hanstock, T. L., Garg, M. L., & Hazell, P. (2007) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2007.00189.x · Cited by 43
Fermented milk containing Bifidobacterium lactis DN‐173 010 improved self‐reported digestive comfort amongst a general population of adults. A randomized, open‐label, controlled, pilot study
Guyonnet, D., Woodcock, A. J., Stefani, B., TREVISAN, C., & Claire, H. A. L. L. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2008.00366.x · Cited by 45
Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial
Fukudo, S., Endo, Y., Hongo, M., Nakajima, A., Abe, T., Kobayashi, H., Nakata, T., Nakajima, T., Sameshima, K., Kaku, K., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30165-1 · Cited by 50
LIFELAX – diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial
Speed, C., Heaven, B., Adamson, A., Bond, J. B., Corbett, S. S., Lake, A. A., May, C. R., Vanoli, A., McMeekin, P. J., Moynihan, P. J., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14520 · Cited by 44
Patient-Reported Outcomes for Irritable Bowel Syndrome Are Associated With Patients' Severity Ratings of Gastrointestinal Symptoms and Psychological Factors
Lackner, J. M., Jaccard, J. J., Baum, C., Smith, A., Krasner, S. S., Katz, L., Firth, R. S., Raby, T., & Powell, C. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.06.014 · Cited by 45
Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children.
Saneian, H., Pourmoghaddas, Z., Roohafza, H., & Gholamrezaei, A. (2015) · Gastroenterology and hepatology from bed to bench. · Cited by 43
Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
Pourmoghaddas, Z., Saneian, H., Roohafza, H., & Gholamrezaei, A. (2014) · BioMed Research International · doi:10.1155/2014/191026 · Cited by 43
A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children
Eftekhari, K., Vahedi, Z., Aghdam, M. K., & Diaz, D. N. (2015) · Iranian Journal of Pediatrics · doi:10.5812/ijp.2616 · Cited by 44
New Developments in the Treatment of Functional Dyspepsia
Stanghellini, V., Ponti, F. D., GIORGIO, R. D., Barbara, G., Tosetti, C., & Corinaldesi, R. (2003) · Drugs · doi:10.2165/00003495-200363090-00003 · Cited by 43
The accuracy of patient‐reported measures for GI symptoms: a comparison of real time and retrospective reports
Lackner, J. M., Jaccard, J. J., Keefer, L., Firth, R., Carosella, A. M., Sitrin, M. D., & Brenner, D. M. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12466 · Cited by 42
Randomized‐controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1‐week trial of acid suppression predict symptom response?
Talley, N. J., Vakil, N. B., Lauritsen, K., van Zanten, S. V., Flook, N. W., Bolling‐Sternevald, E., Persson, T., Björck, E., Lind, T., & ON BEHALF OF THE STARS I STUDY GROUP (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03410.x · Cited by 42
The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome
Porcelli, P., Carne, M. D., & Leandro, G. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.11.010 · Cited by 44
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
Porcari, S., Fusco, W. G., Spivak, I., Fiorani, M., Gasbarrini, A., Elinav, E., Cammarota, G., & Ianiro, G. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00357-6 · Cited by 45
Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer
Bartlett, L., Sloots, K., Nowak, M. J., & Ho, Y. H. (2011) · Techniques in Coloproctology · doi:10.1007/s10151-011-0713-5 · Cited by 40
Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial
Lauche, R., Kumar, S., Hallmann, J., Lüdtke, R., Rampp, T., Dobos, G., & Langhorst, J. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2016.04.002 · Cited by 43
The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up
Rej, A., Shaw, C. C., Buckle, R. L., Trott, N., Agrawal, A., Mosey, K., Sanders, K., Allen, R., Martin, S., Newton, A., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.05.004 · Cited by 41
Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review
Browne, P., Nagelkerke, S., van Etten-Jamaludin, F. V., Benninga, M., & Tabbers, M. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1540298 · Cited by 32
Effect of a gastro‐protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: A double‐blind placebo‐controlled study in Japan
Miwa, H., Osada, T., Nagahara, A., Ohkusa, T., Hojo, M., Tomita, T., Hori, K., Matsumoto, T., & Sato, N. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04446.x · Cited by 39
Quality of Life and Illness Costs in Irritable Bowel Syndrome
Simrén, M., Brazier, J. E., Coremans, G., Dapoigny, M. C., Müller-Lissner, S. A., Pace, F., Smout, A. J. P. M., Stockbrügger, R. W., Vatn, M. H., & Whorwell, P. J. (2004) · Digestion · doi:10.1159/000079846 · Cited by 39
Efficacy of Current Drug Therapies in Irritable Bowel Syndrome: What Works and Does Not Work
Schoenfeld, P. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.002 · Cited by 39
Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics
Talley, N. J., Locke, G. R., Herrick, L. M., Silvernail, V. M., Prather, C. M., Lacy, B. E., DiBaise, J. K., Howden, C. W., Brenner, D. M., Bouras, E. P., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.02.002 · Cited by 38
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?
Hsu, Y., Liou, J., Yang, T. H., Hsu, W.-L., Lin, H.-J., Wu, H.-T., Lin, J. T., Wang, H. P., & Wu, M. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0334-1 · Cited by 38
Gastrointestinal autonomic neuropathy in diabetes
Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102718 · Cited by 38
Low FODMAP Diet Is Not Effective in Children with Functional Abdominal Pain: A Randomized Controlled Trial
Boradyn, K. M., Przybyłowicz, K. E., & Jarocka‐Cyrta, E. (2020) · Annals of Nutrition and Metabolism · doi:10.1159/000510795 · Cited by 38
Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation
Cash, B. D., & Chey, W. D. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02696.x · Cited by 38
A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial
Sadrin, S., Sennoune, S. R., Gout, B., Marque, S., Moreau, J., Zinoune, K., Grillasca, J., Pons, O., & Maixent, J. M. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.12.009 · Cited by 38
Functional Abdominal Pain: Time to Get Together and Move Forward
Nurko, S., & Lorenzo, C. D. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818936d1 · Cited by 38
Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome – a European perspective
Heading, R. C., Bardhan, K. D., Hollerbach, S., Lanas, Á., & FISHER, G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02937.x · Cited by 37
Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients
Dobbin, A., Dobbin, J., Ross, S., Graham, C., & Mj, F. (2013) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2013.104 · Cited by 36
Where Does Hypnotherapy Stand in the Management of Irritable Bowel Syndrome? A Systematic Review
Gholamrezaei, A., Ardestani, S. K., & Emami, M. H. (2006) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2006.12.517 · Cited by 37
Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
Choi, M., Rhee, P., Park, H., Lee, O. Y., Lee, K. J., Choi, S. C., Seol, S. Y., Chun, H. J., Rew, J., Lee, D. H., et al. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14117 · Cited by 36
Stepped treatment of older adults on laxatives. The STOOL trial
Mihaylov, S. I., Stark, C. B., McColl, E., Steen, N., Vanoli, A., Rubin, G. P., Curless, R., Barton, R. E., & Bond, J. B. (2008) · Health Technology Assessment · doi:10.3310/hta12130 · Cited by 36
Constipation assessment scales in adults: a literature review including the new Bowel Function Index
Coffin, B., & Caussé, C. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.53 · Cited by 36
Consensus statement on depression, anxiety, and functional gastrointestinal disorders.
Ballenger, J. C., Davidson, J. R. T., Lecrubier, Y., Nutt, D., Lydiard, R. B., & Mayer, E. A. (2001) · PubMed · Cited by 36
Emerging drugs for autonomic dysfunction in Parkinson's disease
Perez‐Lloret, S., Rey, M. V., Traon, A. P., & Rascol, O. (2013) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2013.766168 · Cited by 35
Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial
Hoekman, D. R., Vlieger, A. M., Stokkers, P. C. F., Mahmmod, N., Rietdijk, S. T., de Boer, N. K. H., de Meij, T. G. J., Frankenhuis, C., D’Haens, G., & Benninga, M. A. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa241 · Cited by 36
The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial
Farzamnia, S., Shavakhi, A., Minakari, M., Peykar, M., Taghipour, G., Tayebi, A., Hashemi, H., & Shavakhi, S. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.135157 · Cited by 34
A systematic review of minimal-contact psychological treatments for symptom management in Irritable Bowel Syndrome
Pajak, R., Lackner, J. M., & Kamboj, S. K. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.05.007 · Cited by 41
Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy
Krol, R., Smeenk, R. J., van Lin, E. N. J. T., & Hopman, W. P. M. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1593-5 · Cited by 34
Psychobiology of the placebo response
Klosterhalfen, S., & Enck, P. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.01.015 · Cited by 33
The treatment of irritable bowel syndrome
Thompson, W. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01312.x · Cited by 34
Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning?
Holtmann, G., & Talley, N. J. (2018) · Gut · doi:10.1136/gutjnl-2017-314775 · Cited by 33
Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders
Chuah, K. H., Cheong, S. Y., Lim, S. Z., & Mahadeva, S. (2022) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13082 · Cited by 33
Do physicians correctly assess patient symptom severity in gastro‐oesophageal reflux disease?
Fallone, C. A., Guyatt, G. H., Armstrong, D., Wiklund, I. E., Degl’Innocenti, A., Heels-Ansdell, D., Barkun, A. N., Chiba, N., van Zanten, S. J. O. V., El-Dika, S. S., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02257.x · Cited by 33
Un consenso latinoamericano sobre el síndrome del intestino irritable
Valenzuela, J. E., Alvarado, J., Cohen, H., Damiao, A. O., Francisconi, C. F. D. M., Frugone, L., González, J. C., Hernández, A., Iade, B., Lopes, M. H., et al. (2004) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)70470-1 · Cited by 33
Self-citation
Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms
Wang, A. J., Liang, M. J., Jiang, A., Jin, L., Xiao, Y., Peng, S., Chen, J., Wen, W. P., & Chen, M. H. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06868.x · Cited by 32
Probiotics in functional bowel disorders
Hod, K., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.003 · Cited by 33
Cognitive Factors Affect Treatment Response to Medical and Psychological Treatments in Functional Bowel Disorders
Weinland, S. R., Morris, C. B., Dalton, C. B., Hu, Y., Whitehead, W. E., Toner, B. B., Diamant, N. E., Leserman, J., Bangdiwala, S. I., & Drossman, D. A. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.748 · Cited by 32
Self-citation
On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study
Ducrotté, P., Grimaud, J., Dapoigny, M., Personnic, S., O'Mahony, V., & Andro-Delestrain, M. (2013) · International journal of clinical practice · doi:10.1111/ijcp.12333 · Cited by 31
Antibiotics and Probiotics for Irritable Bowel Syndrome
Goodoory, V. C., & Ford, A. C. (2023) · Drugs · doi:10.1007/s40265-023-01871-y · Cited by 32
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents
Sainsbury, A., & Ford, A. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10387203 · Cited by 36
Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States
Gudleski, G. D., Satchidanand, N., Dunlap, L. J., Tahiliani, V., Li, X., Keefer, L., & Lackner, J. M. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.07.006 · Cited by 32
Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire
van Zanten, S. V., Armstrong, D., Barkun, A. N., Junghard, O., WHITE, R. J., & Wiklund, I. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03271.x · Cited by 31
Effect of an oral bulking agent and a rectal laxative administered alone or in combination for the treatment of constipation
Bouchoucha, M. L., Faye, A., Savarieau, B., & Arsac, M. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)94953-6 · Cited by 31
Placebo response in pharmacological trials in patients with functional dyspepsia—A systematic review and meta‐analysis
Bosman, M., Smeets, F. G. M., Elsenbruch, S., Tack, J. F., Simrén, M., Talley, N. J., Winkens, B., Masclee, A., & Keszthelyi, D. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14474 · Cited by 31
Self-citation
IBS and the role of otilonium bromide
Boeckxstaens, G. E., Corazziari, E. S., Mearin, F., & Tack, J. F. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1598-0 · Cited by 30
Self-citation
The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
Shin, S. Y., Cha, B. K., Kim, W., Park, J. Y., Kim, J. W., & Choi, C. H. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19160 · Cited by 33
Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial
Shin, S. Y., Park, S., Moon, J. M., Kim, K., Kim, J. W., Chun, J., Lee, T. H., & Choi, C. H. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21202 · Cited by 31
[Prevalence and clinical characteristics of the IBS subtypes according to the Rome III criteria in patients from a clinical, multicentric trial. A report from the Mexican IBS Working Group].
Schmulson, M. J., Vargas, J. B., López‐Colombo, A., Remes-Troche, J. M., & López-Alvarenga, J. C. (2010) · PubMed · Cited by 30
Self-citation
A Deep Convolutional Neural Network Approach to Classify Normal and Abnormal Gastric Slow Wave Initiation From the High Resolution Electrogastrogram
Agrusa, A. S., Gharibans, A. A., Allegra, A. B., Kunkel, D. C., & Coleman, T. P. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2922235 · Cited by 29
Systematic review: self‐management support interventions for irritable bowel syndrome
Dorn, S. D. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04374.x · Cited by 29
Probiotic treatment of irritable bowel syndrome in children
Martens, U., Enck, P., & Zieseniß, E. (2010) · PubMed · doi:10.3205/000096 · Cited by 29
Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome
Self, M. M., Williams, A. E., Czyzewski, D. I., Weidler, E. M., & Shulman, R. J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12590 · Cited by 28
Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.
Gholamrezaei, A., Zolfaghari, B., Farajzadegan, Z., Nemati, K., Daghaghzadeh, H., Tavakkoli, H., & Emami, M. H. (2011) · PubMed · Cited by 28
Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
Lackner, J. M., & Jaccard, J. J. (2021) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000648 · Cited by 31
White Paper AGA: Functional Dyspepsia
Vakil, N. B., Howden, C. W., Moayyedi, P., & Tack, J. F. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.013 · Cited by 28
Self-citation
A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance
Gallagher, A. M., Meijer, G. W., Richardson, D. P., Rondeau, V., Skarp, M., Stasse-Wolthuis, M., Tweedie, G. C., & Witkamp, R. F. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003618 · Cited by 27
Management of functional dyspepsia: Unsolved problems and new perspectives
Madisch, A. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i42.6577 · Cited by 27
Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population
Eales, J., Gibson, P. G., Whorwell, P. J., Kellow, J. E., Yellowlees, A., Perry, R. H. J., Edwards, M., King, S., Wood, H., & Glanville, J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16670075 · Cited by 28
Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome
Bahrudin, M. F., Rani, R. A., Tamil, A. M., Mokhtar, N. M., & Ali, R. A. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05695-3 · Cited by 28
Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis
Xie, C.-R., Tang, B., Shi, Y., Peng, W.-Y., Ye, K., Tao, Q., Yu, S., Zheng, H., & Chen, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853011 · Cited by 30
“The low FODMAP diet is effective to relieve symptoms (Irvine et al., 2016) and improving the quality of life with IBS in comparison with habitual diet or high FODMAP diet (Schumann et al.”
Background
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points
Lacy, B. E., Chang, L., Rao, S. S. C., Heimanson, Z., & Sayuk, G. S. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.01.010 · Cited by 27
Gastric Alimetry® Test Interpretation in Gastroduodenal Disorders: Review and Recommendations
Foong, D., Calder, S. S., Varghese, C., Schamberg, G., Xu, W., Daker, C., Ho, V., Andrews, C. N., Gharibans, A. A., & O’Grady, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206436 · Cited by 26
One‐week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks’ treatment with esomeprazole: a randomized, placebo‐controlled study
van Zanten, S. V., Flook, N. W., Talley, N. J., Vakil, N. B., Lauritsen, K., Bolling‐Sternevald, E., Persson, T., Björck, E., Svedberg, L.-E., & ON BEHALF OF THE STARS II STUDY GROUP (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03409.x · Cited by 25

Authors: Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B.
Affiliations: St. Michael's Hospital (CA)
Universitair Ziekenhuis Leuven (BE)
Mayo Clinic (US)
National University of Singapore (SG)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Hospital General de México (MX)
University of North Carolina at Chapel Hill (US)
Cedars-Sinai Medical Center (US)
Corresponding author: Tack, Jan
ORCID: Tack, Jan
Crowell, Michael D.
Gwee, Kok Ann
Schmulson, Max J.
Whitehead, William E.
Spiegel, Brennan
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2016-05
Volume: 150
Issue: 6
Pages: 1469-1480.e1
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2016.02.010
OpenAlex: W2065994042
Cited by: 550
References: 151
Citations by year: 2026: 7 · 2025: 7 · 2024: 17 · 2023: 12 · 2022: 19 · 2021: 25 · 2020: 22 · 2019: 22 · 2018: 31 · 2017: 22 · 2016: 20
FWCI: 5.29
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
Keywords: functional gastrointestinal disorders, clinical trial design, sham procedure, expectancy effects, nocebo, patient-reported outcome measures, intention-to-treat analysis, CONSORT guidelines, clinical trial registration, regulatory guidelines
MeSH terms: Gastrointestinal Diseases, Research Design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Design of Treatment Trials for Functional Gastrointestinal Disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks